about
Short-term tocolytics for preterm delivery - current perspectivesNon-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed modelNifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolyticHydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a nAn integrated pharmacokinetics ontology and corpus for text mining.Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cellsPredicting the glomerular filtration rate in bariatric surgery patients.Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study.Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam.Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide.Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence SyndromePharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes MellitusThe Cancer Drug Fraction of Metabolism Database
P50
Q26995337-E0837067-4A06-4FF1-97E7-0E1093900607Q33593601-16897856-6B33-4592-88A9-2067DE956490Q33688800-179482FA-1DC5-461D-AF19-0DA3BF3AA045Q34315216-F58FACDF-CA12-4D3B-BAF7-5F8DC30AC288Q34572334-1F239C60-1CE5-4667-A23E-A326F5E82E42Q37621456-895C0A6E-6A9D-4F19-964A-5D7EAD26407BQ37622270-23241B6E-D26C-4FA9-A390-6D9399BA584BQ37671788-70D82D79-12E3-47AF-B35A-7ACF1230308FQ39756295-FF711C7E-9534-470F-AD37-AEE4E8027A4AQ45248668-36973FD4-7713-4B81-8478-E701A42614F7Q47672239-87AF9FFF-E1AC-4E70-89CA-4FF472B9EBB7Q89690304-0B66310C-94EC-4B82-9457-1BE5B8060A8BQ92206425-D55987DB-DA96-4FEB-852F-E8D824A6E48BQ92801941-5BB4F932-3E9D-4442-883D-D148F76202C8
P50
description
researcher ORCID ID = 0000-0002-6554-0695
@en
wetenschapper
@nl
name
Sara K Quinney
@ast
Sara K Quinney
@en
Sara K Quinney
@es
Sara K Quinney
@nl
type
label
Sara K Quinney
@ast
Sara K Quinney
@en
Sara K Quinney
@es
Sara K Quinney
@nl
prefLabel
Sara K Quinney
@ast
Sara K Quinney
@en
Sara K Quinney
@es
Sara K Quinney
@nl
P21
P31
P496
0000-0002-6554-0695